Ramzi Salloum, Ph.D., associate director for community outreach and engagement at the UF Health Cancer Institute, has been elected vice chair of the Florida Cancer Control and Research Advisory Council.
Naomi Parker, Ph.D., an assistant scientist in the University of Florida’s Department of Health Outcomes and Biomedical Informatics, never expected her path from rural Southeast Georgia to lead to cancer communication research.
Students and faculty members in the Division of Implementation Science and Health Interventions will feature prominently in the 18th Annual Conference on the Science of Dissemination and Implementation in Health.
Professor Ramzi Salloum, Ph.D., has been appointed as the Associate Chair for Research in the Department of Health Outcomes and Biomedical Informatics (HOBI). In this new role, he will focus on supporting faculty and trainees around strategic funding opportunities for research.
Working with oncologists, Carma Bylund, Ph.D., and study first author Naomi Parker, Ph.D., both from the UF Department of Health Outcomes and Biomedical Informatics, are piloting an “information prescription” to steer patients to sources of evidence-based information like the American Cancer Society.
“Our goal is to understand how we can meet the real-world needs of cancer survivors and caregivers, with a focus on quality of life,” said Kathryn Pluta, Ph.D.
“This fellowship is a great opportunity to dive deeply into the needs of patients and providers and address their barriers to lung cancer screening.” The National Cancer Institute awarded a prestigious fellowship in July to dual M.D./Ph.D. student Miranda Reid to…
Ramzi Salloum, Ph.D., Professor and Division Director for Implementation Science and Health Interventions has been appointed to serve on the Science of Implementation in Health and Healthcare Study Section (SIHH), a standing study section in the Center for Scientific Review at the National Institutes of Health (NIH).
“Excessive screening opens the door for a lot of negative consequences,” said Jennifer LeLaurin, Ph.D., an assistant professor of health outcomes and biomedical informatics at the University of Florida and lead author of the new study.
Rahma Mkuu, Ph.D. Rahma S. Mkuu, Ph.D., answers questions about the first device approved by the FDA for cervical cancer screening. The device from the company Teal Health has an accuracy for detecting human papillomavirus (HPV) that equals tests conducted in a medical office. Nearly all cervical cancers…
